CIK细胞联合紫杉醇治疗上皮性卵巢癌的初步研究 |
| |
引用本文: | 肖梅,艾月琴,张闯,张燕,高艳荣,胡建华,贾绍昌.CIK细胞联合紫杉醇治疗上皮性卵巢癌的初步研究[J].现代保健,2014(33):150-153. |
| |
作者姓名: | 肖梅 艾月琴 张闯 张燕 高艳荣 胡建华 贾绍昌 |
| |
作者单位: | 中国人民解放军第81医院,江苏南京210002 |
| |
摘 要: | 目的:探讨自体多种细胞因子诱导的杀伤细胞(CIK)输注同步化疗紫杉醇治疗上皮性卵巢癌患者的综合治疗方法,观察安全性和临床疗效。方法:分析2011年11月-2013年11月在本院接受自体CIK细胞输注同步联合紫杉醇治疗的上皮性卵巢癌患者17例。检测治疗前后患者淋巴细胞亚群和血清细胞因子的变化,观察其临床疗效和不良反应。结果:治疗过程中未出现明显治疗相关不良反应,评估后客观有效率(CR+PR)88%。治疗后外周血CD3^+、CD3^+CD8^+、CD3^+CD56^+细胞比例较治疗前明显升高(P〈0.05),CD3^+CD4^+比例和CD4^+CD25^+Treg细胞比例下降。治疗后血清中白介素-2(IL-2)、γ-干扰素(IFN-γ)、肿瘤坏死因子-α(TNF-α)较治疗前明显上升(P〈0.05)。结论:自体CIK细胞同步输注联合紫杉醇治疗上皮性卵巢癌,可改善患者免疫功能,提高患者Th1类细胞因子水平,是一种有前景的治疗上皮性卵巢癌治疗手段。
|
关 键 词: | 卵巢癌 多种细胞因子诱导的杀伤细胞 免疫治疗联合化疗 |
The Preliminary Study on Epithelial Ovarian Cancer Patients Treated with Cytokine Induced Killers Combined Paclitaxel |
| |
Institution: | XIAO Mei, AI Yue-qin, ZHANG Chuang, et al( No. 81 Hospital ofPLA, Nanjing 210002, China) |
| |
Abstract: | Objective: To investigate safety and preliminary clinical effects on epithelial ovarian cancer patients treated with autologous cytokine induced killers(CIK) synchronously combined paclitaxel.Method: 17 cases of epithelial ovarian cancer from November 2011 to November 2013 in our hospital were treated with CIK synchronously combined paclitaxel.The lymphocyte subgroup and Th1 type cytokines(IL-2、IFN-γ、TNF-α) level in serum were examined, the safety and clinical effects were also observed.Result:No obvious side effects occurred during and after treatments,the objective response rate was 88%. The levels of CD3^+,CD3^+CD8^+ and CD3^+CD56^+ were significantly increased after treatment compared before treatment(P0.05), while CD3^+CD4^+ and CD4^+CD25^+Treg were significantly decreased. The serum levels of IL-2, IFN-γ and TNF-α increased significantly after treatment(P0.05).Conclusion: The autologous CIK synchronously combined paclitaxel can improve the immunological function and elicit Th1 immune responses, which encourage that the CIK is one of promising treatments for epithelial ovarian cancer. |
| |
Keywords: | Ovarian cancer Cytokine induced killer cells Immunotherapy combined chemotherapy |
本文献已被 维普 等数据库收录! |
|